BMS-820132 is an orally active and partial
[1]. Shi Y, et al. Discovery of a Partial Glucokinase Activator Clinical Candidate: Dietl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)metl)phosphonate (BMS-820132). J Med Chem. 2022;65(5):4291-4317.
















